重症肌无力
碳酸酐酶
类风湿性关节炎
碳酸酐酶Ⅱ
乙酰胆碱受体
化学
免疫组织化学
自身免疫性疾病
碳酸酐酶Ⅰ
内科学
骨骼肌
内分泌学
胞浆
抗体
分子生物学
医学
免疫学
受体
生物化学
酶
生物
作者
Ailian Du,Ailian Du,Huimin Ren,Ailian Du,Huimin Ren,Chuanzhen Lü,Jianglong Tu,Chuanshan Xu,Yongan Sun
出处
期刊:Autoimmunity
[Informa]
日期:2009-01-01
卷期号:42 (3): 209-215
被引量:29
标识
DOI:10.1080/08916930802668610
摘要
Myasthenia gravis (MG) is considered as an autoimmune disease mainly mediated by antibodies against acetylcholine receptor. In recent years, other targets related to MG have been the subject of interest. Our previous research found that protein P25 was lower in muscles of MG patients using two-dimensional electrophoresis. In present study, anti-serum to P25 was prepared, immunohistochemistry and ATPase staining revealed that P25 was a muscle specific cytosolic protein and was mainly distributed in type I muscle fibers. Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry and precise molecular weight derived from mass spectrometer identified P25 as carbonic anhydrase III (CA III). Some members of CA family are related to autoimmune diseases and CA III is recently reported to be involved in rheumatoid arthritis. The results of immunoblot in this report showed that the level of CA III is specifically insufficient in the skeletal muscle of MG patients. The possible roles that CA III play in MG need further elucidation.
科研通智能强力驱动
Strongly Powered by AbleSci AI